Absence of mutations in the promoter of the COLlAl gene of type i collagen in patients with osteogenesis imperfecta type I

Journal of Medical Genetics

Volumn 32, Issue 9, 1995, Pages 697-700

  Willing, Marcia C ^a   Slayton, Rebecca L ^b   Pitts, Sara H ^a   Deschenes, Sachi P ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; DNA FRAGMENT;

ARTICLE; CYTOPLASM; DENATURING GRADIENT GEL ELECTROPHORESIS; GENE; GENE MUTATION; HUMAN; OSTEOGENESIS IMPERFECTA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM;

AMINO ACID SEQUENCE; BASE SEQUENCE; CELLS, CULTURED; COLLAGEN; DNA; FIBROBLASTS; HUMAN; MOLECULAR SEQUENCE DATA; MUTATION; OSTEOGENESIS IMPERFECTA; PROMOTER REGIONS (GENETICS); SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TATA BOX;

EID: 0029033298     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.32.9.697     Document Type: Article

References (37)

1. Sillence, D.; Senn, A.; Danks, D. Genetic heterogeneity in osteogenesis imperfecta J Med Genet 1979 10.1136/jmg.16.2.101 16 101
2. Sykes, B.; Francis, M.; Phil, D.; Smith, R. Altered relation of two collagen types in osteogenesis imperfecta N Engl J Med 1977 10.1056/NEJM197705262962104 296 1200
3. Wenstrup, R.J.; Willing, M.C.; Starman, B.J.; Byers, P.H. Distinct biochemical phenotypes predict clinical severity in nonlethal variants ofosteogenesis imperfecta AmJHum Genet 1990 46 975
4. Barsh, G.S.; David, K.E.; Byers, P.H. Type I osteogenesis imperfecta: a nonfunctional allele for proaal (I) chains of type I procollagen. Proc Natl Acad Sci 1982 79 3838
5. Rowe, D.; Shapiro, J.; Poirier, M.; Schlesinger, S. Diminished type I collagen synthesis and reduced alpha 1 (I) collagen messenger RNA in cultured fibroblasts from patients with dominantly inherited (type I) osteogenesis imperfecta Jf Clin Invest 1985 10.1172/JCI112012 76 604
6. Genovese, C.; Rowe, D. Analysis of cytoplasmic and nuclear messenger RNA in fibroblasts from patients with type I osteogenesis imperfecta Methods Enzymol 1987 10.1016/0076-6879(87)45012-X 145 223
7. Willing, M.C.; Pruchno, C.J.; Byers, P.H. Molecular heterogeneity in osteogenesis imperfecta type I. Am J Med Genet 1993 10.1002/ajmg.1320450214 45 223
8. Willing, M.C.; Pruchno, C.J.; Atkinson, M.; Byers, P.H. Osteogenesis imperfecta type I is commonly due to a COLlAl null allele of type I collagen Am Jf Hum Genet 1992 51 508
9. Willing, M.C.; Deschenes, S.P.; Scott, D.A. Osteogenesis imperfecta type I: molecular heterogeneity for COLlAl null alleles of type I collagen Am Jf Hum Genet 1994 55 638
10. Saiki, R.K.; Gelfand, D.H.; Stoffel, S. Primer-directed enzymatic amplification ofDNA with a thermostable DNA polymerase Science 1988 239 1 487-9
11. Bornstein, P.; McKay, J.; Morishima, J.K. Regulatory elements in the first intron contribute to transcriptional control of the human Proc Nad Acad Sci USA 1987 10.1073/pnas.84.24.8869 84 8869
12. Willing, M.C.; Cohn, D.H.; Byers, P.H. Frameshift mutation near the 3' end of the COLlAl gene of type I collagen predicts an elongated proal(I) chain and results in osteogenesis imperfecta type I. JClin Invest 1990 10.1172/JCI114424 85 282
13. Myers, R.; Lumelsky, N.; Lerman, L. Detection of single base substitutions in total genomic DNA Nature 1985 10.1038/313495a0 313 495
14. Myers, R.; Sheffield, V.; Cox, D. Mutation detection by PCR, GC-clamps, and denaturing gradient gel electrophoresis 1989 71
15. Orita, M.; Iwahana, H.; Kanazawa, H. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms Proc Nad Acad Sci USA 1989 10.1073/pnas.86.8.2766 86 2766
16. Poduslo, S.; Dean, M.; Ulricke, K.; O'Brien, S. Detecting highresolution polymorphisms in human coding loci by combining PCR and single-stranded conformation polymorphism (SSCP) analysis. Am J Hum Genet 1991 49 106
17. Sanger, R.; Nicklen, F.S.; Coulson, A.R. DNA sequencing with chain-termination inhibitors Proc Nad Acad Sci USA 1979 10.1073/pnas.74.12.5463 74 5463
18. Pruchno, C.J.; Willing, M.C.; Starman, B.J. Inefficient splicing and production of both a normal and shortened mRNA from the same COLlAl allele of type I collagen in a father and son with osteogenesis imperfecta (01) Am Jf Hum Genet 1989 45 213
19. Stover, M.L.; Primorac, D.; Liu, S.C. Defective splicing of mRNA from one COLlAI allele of type I collagen in nondeforming (type I) osteogenesis imperfecta Jf Clin Invest 1993 10.1172/JCI116794 92 1994
20. Kozak, M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes Cell 1986 10.1016/0092-8674(86)90762-2 44 283
21. Gilman, J.G.; Mishima, N.; Wen, X.J. Upstream promoter mutation associated with a modest elevation of fetal hemoglobin expression in human adults Blood 1988 10.1182/blood.V72.1.78.78 72 78
22. Efremov, D.G.; Dimovski, A.J.; Huisman, T.H.J. The-158 (C-T) promoter mutation is responsible for the increased transcription of the 3'y gene in the Atlanta type of hereditary persistence of fetal hemoglobin Blood 1994 10.1182/blood.V83.11.3350.3350 83 3350
23. Atweh, G.F.; Zhu, XX, Brickner; H.E. The, B-globin gene on the Chinese 8p-thalassemia chromosome carries a promoter mutation Blood 1987 10.1182/blood.V70.5.1470.1470 70 1470
24. Poncz, M.; Ballantine, M.; Solowiejczyk, D. [I3Thalassemia in a Kurdish Jew: single base changes in the T-A-T-A box J Biol Chem 1982 10.1016/S0021-9258(20)65092-X 257 5994
25. Baklouti, F.R.; Ouazana, C.; Gonnet, A. Beta+-thalassemia in cis of a sickle cell gene: occurrence of a promoter mutation on a beta s chromosome Blood 1989 74 181722
26. Meloni, A.; Rosatelli, M.; Faa, V. Promoter mutations producing mild 1-thalassaemia in the Italian population Br Jf Haematol 1992 10.1111/j.1365-2141.1992.tb08904.x 80 222
27. Divoky, V.; Baysal, E.; Schiliro, G. A mild type of Hb S-0+-thalassemia [-92(C-. T)] in a Sicilian family Am Jf Hematol 1993 10.1002/ajh.2830420216 42 225
28. Balta, G.; Brickner, H.E.; Takegawa, S. Increased expression of the G7 and AX globin genes associated with a mutation in the Ay enhancer Blood 1994 10.1182/blood.V83.12.3727.3727 83 3727
29. Gilman, J.G.; Michima, N.; Wen, X.J. Distal CCAAT box deletion in the Ay globin gene of two black adolescents with elevated fetal y globin Nucleic Acids Res 1988 10.1093/nar/16.22.10635 16 10635
30. Koivisto, U.M.; Palvimo, J.J.; Janne, O.A. A single-base substitution in the proximal Spl site of the human low density lipoprotein receptor promoter as a cause of heterozygous familial hypercholesterolemia. Proc Nad Acad Sci USA 1994 91 10526
31. Stowell, K.M.; Figueiredo, M.S.; Brownlee, G.G. Liverpool: a new British family with mild haemophilia B associated with a-6 G to A mutation in the factor IX promoter BrJ Haematol 1993 10.1111/j.1365-2141.1993.tb08667.x 85 188
32. Giannelli, F.; Green, P.M.; High, K.A. Haemophilia B: database of point mutations and short additions and deletions-fourth edition 1993 10.1093/nar/21.13.3075 Nucleic Acids Res 21 3075
33. Newburger, P.E.; Skalnik, D.G.; Hopkins, P.J. Mutations in the promoter region of the gene for gp9l-phox in X-linked chronic granulomatous disease with decreased expression of cytochrome b558 Jf Clin Invest 1994 10.1172/JCI117437 94 1205
34. Top, B.; Uitterlinden, A.G.; van der Zee, A. Absence of mutations in the promoter region ofthe low density lipoprotein receptor gene in a large number of familial hypercholesterolaemia patients as revealed by denaturing gradient gel electrophoresis Hum Genet 1992 10.1007/BF00219185 89 561
35. Vitiello, L.; Mostacciuolo, M.L.; Oliviero, S. Screening for mutations in the muscle promoter region and for exonic deletions in a series of 115 DMD and BMD patients J Med Genet 1992 10.1136/jmg.29.2.127 29 127
36. Tsui, L.-C. The spectrum of cystic fibrosis mutations Trends Genet 1992 10.1016/0168-9525(92)90301-J 8 392
37. The hemoglobinopathies Scriver, C.R. The metabolic basis of inherited disorders